Spotlight On... WuXi partners up for genomics in China; Medidata stumbles in wire fraud case; and more...

Chinese CRO WuXi PharmaTech has teamed up with IT firm Huawei to develop a cloud-based data management platform to support the country's precision medicine initiative. The deal, through WuXi's NextCODE business, will match the CRO's expertise in genomics with Huawei's experience in building digital infrastructure, the companies said. More

> Clinical trial tech firms PointCross Life Sciences and Xybion are teaming up to market regulatory services to drugmakers ahead of a big shift in FDA rules. News

> A federal judge has refused to rule on a case stemming from the $4.8 million wire transfer fraud that was inflicted on Medidata ($MDSO) in 2014. Story

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.